Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.
about
Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma.
P2860
Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@ast
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@en
type
label
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@ast
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@en
prefLabel
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@ast
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@en
P2093
P2860
P356
P1476
Intrahepatic cholangiocarcinom ...... es to guide potential therapy.
@en
P2093
John T Miura
Kathleen K Christians
Mary Potkonjak
Susan Tsai
T Clark Gamblin
P2860
P304
P356
10.1111/HPB.12504
P577
2015-09-16T00:00:00Z